These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8980410)

  • 21. Long-term complications of chemotherapy for germ cell tumours.
    Chaudhary UB; Haldas JR
    Drugs; 2003; 63(15):1565-77. PubMed ID: 12887263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
    Elias AD; Ayash LJ; Wheeler C; Schwartz G; Tepler I; Gonin R; McCauley M; Mazanet R; Schnipper L; Frei E
    Bone Marrow Transplant; 1995 Mar; 15(3):373-9. PubMed ID: 7599561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.
    Hartmann JT; Fels LM; Knop S; Stolt H; Kanz L; Bokemeyer C
    Invest New Drugs; 2000 Aug; 18(3):281-9. PubMed ID: 10958599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity.
    Sanchez-Gonzalez PD; Lopez-Hernandez FJ; Perez-Barriocanal F; Morales AI; Lopez-Novoa JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3484-95. PubMed ID: 21602180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to prevent nephrotoxicity of anticancer drugs.
    Skinner R
    Curr Opin Oncol; 1995 Jul; 7(4):310-5. PubMed ID: 7578377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
    Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ifosfamide in testicular cancer.
    Loehrer PJ
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):2-5. PubMed ID: 2159186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of cisplatin-induced renal and hepatic side effects in rat through antioxidative and anti-inflammatory properties of Malva sylvestris L. extract.
    Mohamadi Yarijani Z; Godini A; Madani SH; Najafi H
    Biomed Pharmacother; 2018 Oct; 106():1767-1774. PubMed ID: 30119252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children.
    Loebstein R; Atanackovic G; Bishai R; Wolpin J; Khattak S; Hashemi G; Gobrial M; Baruchel S; Ito S; Koren G
    J Clin Pharmacol; 1999 May; 39(5):454-61. PubMed ID: 10234592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of ifosfamide in testicular cancer.
    Schmoll HJ
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):82-95. PubMed ID: 2649987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
    McCaffrey JA; Mazumdar M; Bajorin DF; Bosl GJ; Vlamis V; Motzer RJ
    J Clin Oncol; 1997 Jul; 15(7):2559-63. PubMed ID: 9215825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of Nigella sativa oil on cisplatin induced nephrotoxicity and oxidative damage in rat kidney.
    Farooqui Z; Ahmed F; Rizwan S; Shahid F; Khan AA; Khan F
    Biomed Pharmacother; 2017 Jan; 85():7-15. PubMed ID: 27930989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
    Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
    Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of age on nephrotoxicity following chemotherapy in children.
    Skinner R; Pearson AD; Price L; Coulthard MG; Craft AW
    Br J Cancer Suppl; 1992 Aug; 18():S30-5. PubMed ID: 1503924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
    Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
    Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats.
    Chen N; Aleksa K; Woodland C; Rieder M; Koren G
    Br J Pharmacol; 2008 Apr; 153(7):1364-72. PubMed ID: 18278066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor-risk testicular cancer and high-dose chemotherapy.
    Motzer RJ; Sheinfeld S
    J Clin Oncol; 2003 Nov; 21(22):4073-4. PubMed ID: 14568986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.